Insider Shareholders with Direct Ownership of Eli Lilly & CO (LLY)
This section provides a comprehensive overview of the insiders with direct ownership of Eli Lilly & CO (LLY). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
ELI LILLY & Co Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
| 0 | 29,370,563 | 96,016,978 $72.4 Billion | 265 |
Mar 03, 2025
Reduced 0.0%
|
|
|
David A Ricks
President, Chair, and CEO |
813,197 | 214,723 | 539,613 $407 Million | 35 |
Feb 10, 2025
Added 9.27%
|
| 0 | 398,130 | 436,161 $329 Million | 2 |
May 25, 2017
Reduced 47.02%
|
|
|
Jan M Lundberg
EVP,Science&Tech and Pres. LRL |
59,142 | 16,169 | 198,126 $149 Million | 3 |
Feb 01, 2018
Reduced 7.55%
|
|
Stephen F Fry
SVP, HR & Diversity |
154,279 | 78,482 | 152,631 $115 Million | 21 |
Feb 09, 2022
Added 7.48%
|
|
Daniel Skovronsky
EVP, CSO & Pres. LRL & LLY Imm |
196,471 | 35,010 | 136,660 $103 Million | 22 |
Feb 10, 2025
Added 12.08%
|
|
Jeffrey N Simmons
SVP&Pres. Elanco Animal Health |
53,988 | 55,552 | 135,458 $102 Million | 9 |
May 03, 2018
Reduced 6.25%
|
|
Enrique A Conterno
SVP&Pres, LillyDiab & LillyUSA |
92,666 | 98,922 | 132,962 $100 Million | 11 |
Feb 15, 2019
Reduced 15.83%
|
|
Michael J Harrington
Senior VP and General Counsel |
81,615 | 116,548 | 110,300 $83.2 Million | 9 |
Jun 03, 2019
Reduced 12.67%
|
| 76,765 | 14,934 | 77,659 $58.6 Million | 12 |
Feb 08, 2021
Added 24.65%
|
|
|
Kathi P Seifert
Director |
6,214 | 0 | 77,038 $58.1 Million | 4 |
Nov 16, 2020
Added 1.59%
|
|
Anne E. White
EVP & Pres, Lilly Neuroscience |
83,669 | 19,063 | 74,209 $56 Million | 20 |
Feb 10, 2025
Added 8.43%
|
|
J Erik Fyrwald
Director |
9,521 | 0 | 72,827 $54.9 Million | 44 |
Mar 17, 2025
Added 0.02%
|
|
Myles O'Neill
SVP & Pres., Mfg. Operations |
51,630 | 5,660 | 72,533 $54.7 Million | 7 |
Feb 08, 2021
Added 22.5%
|
|
Franklyn G Prendergast
Director |
802 | 0 | 68,574 $51.7 Million | 1 |
Nov 20, 2017
Added 1.16%
|
|
Jackson P Tai
Director |
13,937 | 0 | 63,524 $47.9 Million | 47 |
Apr 17, 2023
Added 0.01%
|
|
Alfonso G Zulueta
SVP & President, Lilly Int'l |
136,685 | 125,321 | 56,947 $43 Million | 25 |
Feb 08, 2021
Added 33.77%
|
|
Ellen R Marram
Director |
3,657 | 0 | 56,645 $42.7 Million | 6 |
Apr 15, 2019
Added 0.1%
|
|
Ralph Alvarez
Director |
13,608 | 0 | 54,832 $41.4 Million | 87 |
Mar 17, 2025
Added 0.03%
|
|
Patrik Jonsson
EVP&Pres, CardMetHlth, LLY USA |
47,998 | 13,724 | 53,650 $40.5 Million | 15 |
Feb 10, 2025
Added 11.79%
|
|
Michael L Eskew
Director |
6,891 | 0 | 45,080 $34 Million | 5 |
Nov 15, 2021
Added 1.48%
|
|
Anat Ashkenazi
EVP & CFO |
24,630 | 0 | 42,330 $31.9 Million | 4 |
Feb 12, 2024
Added 9.05%
|
|
Edgardo Hernandez
EVP & Pres., Mfg. Operations |
28,709 | 4,134 | 39,748 $30 Million | 12 |
Mar 01, 2025
Reduced 3.07%
|
|
Michael B Mason
EVP & Pres., Lilly Diabetes |
35,704 | 5,670 | 39,284 $29.6 Million | 8 |
Feb 10, 2023
Added 16.96%
|
|
R David Hoover
Director |
1,924 | 0 | 36,284 $27.4 Million | 1 |
Nov 20, 2017
Added 5.04%
|
|
Melissa S Barnes
Chief Eth/Cmpl Ofcr & SVP, ERM |
46,424 | 22,308 | 34,616 $26.1 Million | 16 |
Feb 08, 2021
Added 21.7%
|
|
Leigh Ann Pusey
EVP, Corp. Affairs & Comm. |
40,889 | 9,248 | 31,641 $23.9 Million | 15 |
Feb 10, 2023
Added 10.42%
|
|
Aarti S. Shah
SVP & CIDO |
29,889 | 7,685 | 31,622 $23.9 Million | 9 |
Feb 08, 2021
Added 25.87%
|
|
Anat Hakim
EVP, GC & Secretary |
58,056 | 29,219 | 28,837 $21.8 Million | 14 |
Feb 10, 2025
Added 26.36%
|
|
Ilya Yuffa
EVP & President, LLY Int'l |
27,045 | 5,098 | 28,759 $21.7 Million | 11 |
Feb 10, 2025
Added 19.85%
|
|
Susan Mahony
SVP & Pres., Lilly Oncology |
33,738 | 84,523 | 28,273 $21.3 Million | 7 |
Apr 16, 2018
Reduced 38.07%
|
|
Johna Norton
EVP, Global Quality |
32,458 | 21,173 | 25,428 $19.2 Million | 22 |
Jun 03, 2024
Reduced 21.72%
|
|
Katherine Baicker
Director |
8,026 | 0 | 23,118 $17.4 Million | 8 |
Nov 18, 2024
Added 1.29%
|
|
William G Kaelin Jr
Director |
8,026 | 0 | 21,464 $16.2 Million | 8 |
Nov 18, 2024
Added 1.39%
|
|
Diogo Rau
EVP & CIDO |
30,244 | 10,525 | 19,718 $14.9 Million | 9 |
Feb 10, 2025
Added 25.68%
|
|
Jacob Van Naarden
EVP & Pres., Lilly Oncology |
25,766 | 10,896 | 19,561 $14.8 Million | 12 |
Feb 10, 2025
Added 23.78%
|
|
Marschall S Runge
Director |
7,926 | 0 | 16,593 $12.5 Million | 8 |
Nov 20, 2023
Added 1.98%
|
|
Juan R Luciano
Director |
13,080 | 0 | 16,276 $12.3 Million | 76 |
Mar 17, 2025
Added 0.1%
|
|
Lucas Montarce
EVP & CFO |
3,969 | 467 | 13,969 $10.5 Million | 3 |
Feb 10, 2025
Added 17.17%
|
|
Eric Dozier
EVP, Chief People Officer |
9,614 | 3,875 | 9,838 $7.42 Million | 12 |
Mar 01, 2025
Reduced 9.78%
|
|
Jamere Jackson
Director |
8,026 | 0 | 9,153 $6.9 Million | 8 |
Nov 18, 2024
Added 3.19%
|
|
Alonzo Weems
EVP, ERM & CECO |
8,883 | 5,993 | 7,951 $6 Million | 9 |
Feb 12, 2024
Added 10.68%
|
|
Karen Walker
Director |
5,986 | 0 | 6,248 $4.71 Million | 18 |
Nov 18, 2024
Added 4.61%
|
|
Carolyn R Bertozzi
Director |
6,053 | 0 | 6,243 $4.71 Million | 4 |
Nov 16, 2020
Added 16.63%
|
|
Donald A Zakrowski
SVP, Finance, & CAO |
28,823 | 23,692 | 5,839 $4.4 Million | 30 |
Mar 13, 2025
Reduced 14.62%
|
|
Kimberly H Johnson
Director |
2,972 | 0 | 3,032 $2.29 Million | 46 |
Dec 16, 2024
Added 0.39%
|
|
Gabrielle Sulzberger
Director |
2,504 | 0 | 2,556 $1.93 Million | 40 |
Mar 17, 2025
Added 0.23%
|
|
Mary Lynne Hedley
Director |
1,651 | 0 | 1,918 $1.45 Million | 35 |
Mar 17, 2025
Added 0.62%
|
|
Christi Shaw
SVP and Pres., Lilly Bio-Meds |
27,500 | 27,500 | 0 $0 | 6 |
May 03, 2019
Reduced 100.0%
|